CareDx CDNA Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total Revenue by Product | ||||||
| Patient and digital solutions revenue | $60.94M+32.6% | $56.93M+30.5% | $51.57M+23.2% | $48.02M+20.5% | $45.96M+20.5% | |
| Testing services revenue | $303.97M+18.1% | $274.5M+10.1% | $259.94M+11.9% | $248.58M+13.4% | $257.47M+27.6% | |
| Cost of testing services, product, patient and digital solutions by Product | ||||||
| Patient and digital solutions revenue | $42.22M+34.2% | $38.24M+24.5% | $34.75M+21.9% | $32.34M+19.1% | $31.46M+19.2% | |
| Testing services revenue | $64.03M+12.2% | $62.05M+11.6% | $59.45M+7.7% | $58.19M+5.9% | $57.09M+2.0% | |
| Total Revenue by Geography | ||||||
| United States | $393.72M+19.6% | $359.94M+13.3% | $338.74M+13.8% | $322.76M+14.6% | $329.09M+26.4% | |
| Property, Plant and Equipment, Net by Geography | ||||||
| United States | $127.67M-4.1% | $127.37M-5.4% | $128.03M-5.9% | $131.08M-4.5% | $133.18M-4.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does CareDx break its business down?
- CareDx (CDNA) reports total revenue by product across 2 parts — Patient and digital solutions revenue and Testing services revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does CareDx's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in CareDx's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
